Prostate cancer and Necrosis

Summary:

Necrosis is found among people with Prostate cancer, especially for people who are 60+ old.

The study analyzes which people have Necrosis with Prostate cancer. It is created by eHealthMe based on reports of 31 people who have Prostate cancer from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Prostate cancer?

Prostate cancer is found to be associated with 998 drugs and 1,210 conditions by eHealthMe. Check the latest studies of Prostate cancer.

What is Necrosis?

Necrosis (the death of body tissue) is found to be associated with 745 drugs and 970 conditions by eHealthMe. Check the latest studies of Necrosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

31 people who have Prostate Cancer and Necrosis are studied.

Would you have Necrosis when you have Prostate cancer?

Age of people who have Prostate Cancer and experienced Necrosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 4.55 %
  • 50-59: 4.55 %
  • 60+: 90.91 %

Common co-existing conditions for these people *:

  1. Metastases To Bone (cancer spreads to bone): 6 people, 19.35%
  2. High Blood Pressure: 4 people, 12.90%
  3. Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 3 people, 9.68%
  4. Mucosal Inflammation (infection of mucous membrane): 3 people, 9.68%
  5. Depression: 2 people, 6.45%
  6. Pain: 1 person, 3.23%
  7. Incontinence (lack of moderation or self-control): 1 person, 3.23%
  8. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 3.23%
  9. Cardiac Disorder: 1 person, 3.23%
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 3.23%

Common drugs taken by these people *:

  1. Zytiga: 5 people, 16.13%
  2. Zometa: 3 people, 9.68%
  3. Zoledronic Acid: 3 people, 9.68%
  4. Lupron Depot: 3 people, 9.68%
  5. Xgeva: 3 people, 9.68%
  6. Sunitinib Malate: 3 people, 9.68%
  7. Taxotere: 2 people, 6.45%
  8. Eligard: 2 people, 6.45%
  9. Leuprolide Acetate: 2 people, 6.45%
  10. Xtandi: 2 people, 6.45%

Common symptoms for these people *:

  1. Pain: 3 people, 9.68%
  2. Secretion Discharge: 3 people, 9.68%
  3. Peripheral Vascular Disorder: 2 people, 6.45%
  4. Injection Site Abscess: 2 people, 6.45%
  5. Diarrhea: 2 people, 6.45%
  6. Weakness: 1 person, 3.23%
  7. Henoch-Schonlein Purpura (inflammation of the blood vessels in the skin and other body organs): 1 person, 3.23%
  8. Haemorrhage (bleeding): 1 person, 3.23%
  9. Hallucinations (sensations that appear real but are created by your mind): 1 person, 3.23%
  10. Heart Attack: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Necrosis?

- Check whether Necrosis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Necrosis:

All the conditions that are associated with Necrosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Necrosis and Prostate cancer, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: